Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026)
Northwest Biotherapeutics (NWBO) reported Preferred Dividend Payments of $332,000 for Q2 2026, down 40.7% from $560,000 a year earlier but up 0.3% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Northwest Biotherapeutics' Preferred Dividend Payments came in at $1.15 million, down 6.3% year-over-year; for FY2025, it was $1.32 million, down 7.0% from FY2024.
- By year, Preferred Dividend Payments came in at $1.41 million in FY2024 (-21.4%) and $1.8 million in FY2023.
- Five-year quarterly Preferred Dividend Payments spans a low of $132,000 in Q3 2024 and a high of $568,000 in Q1 2024.
- Year over year, Preferred Dividend Payments gained in three of the last eight quarters, with an average decline of 3.1%.
- The high point for year-over-year Preferred Dividend Payments in five years was Q3 2025 (growth of 167.4%); the low point was Q3 2024 (a decline of 74.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $331,000 (Q1 2026), $137,000 (Q4 2025) and $353,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.00 Bn | 1,140.58 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 639.12 Bn | 557.64 Bn | 17.26 Bn | - |
| 3 | AbbVie | 502.23 Bn | 475.34 Bn | 12.70 Bn | - |
| 4 | Merck | 375.29 Bn | 329.67 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.99 Bn | 266.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.36 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.24 Bn | 197.64 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.36 Bn | 167.56 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | - |
| 10 | Northwest Biotherapeutics | 254.58 Mn | 244.60 Mn | - | 332,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 332,000.00 |
| Mar 31, 2026 | 331,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Sep 30, 2023 | 519,000.00 |
| Jun 30, 2023 | 519,000.00 |
| Mar 31, 2023 | 395,000.00 |
| Sep 30, 2018 | 4.18 Mn |
| Jun 30, 2018 | 3.54 Mn |
| Mar 31, 2018 | 10.06 Mn |
| Dec 31, 2017 | 1.27 Mn |
| Sep 30, 2016 | 3.01 Mn |
| Jun 30, 2016 | 2.64 Mn |
API Access
Northwest Biotherapeutics Preferred Dividend Payments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-dividend-payments", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();